Japan In Vitro Diagnostics Industry Report

Japan In Vitro Diagnostics Industry Report

Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits

This report is an essential source for in-depth information and data relating to Country "Sector" market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the "Sector"in Country.

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• Sector in Country Report
• 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
• 2 Introduction
  • 2.1 What Is This Report About?
  • 2.2 Definitions
    • 2.2.1 In Vitro Diagnostics
    • 2.2.2 Immunochemistry Calibrators and Controls
    • 2.2.3 Immunochemistry Rapid Tests
  • 2.3 Blood Test Reagents
    • 2.3.1 Hematology Test Reagents
    • 2.3.2 Hemostasis Test Reagents
    • 2.3.3 Tissue Typing Reagents
    • 2.3.4 Monoclonal Antibodies
    • 2.3.5 Cytokines and Immunomodulators
    • 2.3.6 Histology and Cytology Reagents
  • 2.4 Microbiology Test Reagents
    • 2.4.1 Bacteriology Test Reagents
    • 2.4.2 Microbiology Calibrators and Controls
    • 2.4.3 Microbiology Rapid Tests
  • 2.5 Infectious Immunology Test Reagents
    • 2.5.1 Bacteriology
    • 2.5.2 Virology
    • 2.5.3 Parasitology
    • 2.5.4 Infectious Immunology Calibrators and Controls
    • 2.5.5 Infectious Immunology Rapid Tests
  • 2.6 Genetic Test Reagents
  • 2.7 Self Testing
  • 2.8 Instruments
• 3 In Vitro Diagnostics Medical Equipment in Japan
  • 3.1 In Vitro Diagnostics Medical Equipment Overall Revenues (2000-2012)
• 4 Clinical Chemistry Test Reagents in Japan
  • 4.1 Clinical Chemistry Test Reagents Overall Revenues (2000-2012)
  • 4.2 Clinical Chemistry Test Reagents Distribution Share (2005-2006)
  • 4.3 Clinical Chemistry Test Reagents Company Share (2005-2006)
• 5 Self Testing in Japan
  • 5.1 Self Testing Overall Revenues (2000-2012)
  • 5.2 Self Testing Distribution Share (2005-2006)
  • 5.3 Self Testing Company Share (2005-2006)
• 6 Immunochemistry Test Reagents in Japan
  • 6.1 Immunochemistry Test Reagents Overall Revenues (2000-2012)
    • 6.1.1 Disease Specific Test Reagents Overall Revenues (2000-2012)
    • 6.1.2 Disease Specific Markers Overall Revenues (2000-2012)
    • 6.1.3 Hormone Related Testing Reagents Overall Revenues (2000-2012)
    • 6.1.4 Drug Related Testing Reagents Overall Revenues (2000-2012)
    • 6.1.5 Rapid Tests Overall Revenues (2000-2012)
    • 6.1.6 Calibrators and Controls Overall Revenues (2000-2012)
  • 6.2 Immunochemistry Test Reagents Distribution Share (2005-2006)
  • 6.3 Immunochemistry Test Reagents Company Share (2005-2006)
  • 6.4 Blood Test Reagents Overall Revenues (2000-2012)
    • 6.4.1 Haematology Test Reagents Overall Revenues (2000-2012)
    • 6.4.2 Hemostatsis Test Reagents Overall Revenues (2000-2012)
    • 6.4.3 Monoclonal Antibodies for Cell Surface Ag Overall Revenues (2000-2012)
    • 6.4.4 Histology/ Cytology Reagents Overall Revenues (2000-2012)
    • 6.4.5 Tissue Typing Reagents Overall Revenues (2000-2012)
    • 6.4.6 Cytokines/ Immunomodulators Overall Revenues (2000-2012)
  • 6.5 Blood Test Reagents Distribution Share
  • 6.6 Blood Test Reagents Company Share
  • 6.7 Infectious Immunology Test Reagents Overall Revenues (2000-2012)
    • 6.7.1 Virology Overall Revenues (2000-2012)
  • 6.8 Infectious Immunology Test Reagents Distribution Share
  • 6.9 Infectious Immunology Test Reagents Company Share
• 7 Instruments in Japan
  • 7.1 Instruments Overall Revenues (2000-2012)
  • 7.2 Instruments Distribution Share (2005-2006)
• 8 Microbiology Test Reagents in Japan
  • 8.1 Microbiology Test Reagents Overall Revenues (2000-2012)
    • 8.1.1 Bacteriology Test Reagents Overall Revenues (2000-2012)
    • 8.1.2 Calibrators and Controls Overall Revenues (2000-2012)
  • 8.2 Microbiology Test Reagents Distribution Share
  • 8.3 Microbiology Test Reagents Company Share
• 9 Genetic Test Reagents in Japan
  • 9.1 Genetic Test Reagents Overall Revenues (2000-2012)
  • 9.2 Genetic Test Reagents Distribution Share (2005-2006)
  • 9.3 Genetic Test Reagents Company Share (2005-2006)
• 10 APPENDIX
  • 10.1 Methodology
  • 10.2 Currency Conversion
  • 10.3 Contact Us
  • 10.4 Disclaimer
• Note: Some content types may not be available in this report